• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOARRAY SOLUTIONS PRECISETYPE HEA MOLECULAR BEADCHIP TEST; MOLECULIAR ERYTHROCYTE TYPING TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOARRAY SOLUTIONS PRECISETYPE HEA MOLECULAR BEADCHIP TEST; MOLECULIAR ERYTHROCYTE TYPING TEST Back to Search Results
Model Number 800-20202-96
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/17/2021
Event Type  malfunction  
Event Description
On (b)(6) 2021 the customer reported two possible discrepancies as the samples typed fya- by hea and fya+ twice by serology and hea.
 
Manufacturer Narrative
Bioarray's technical support specialist reviewed the customer's results and forwarded the results to bioarray's mts department for further review.The internal immucor/bioarray record for this event is pr# (b)(4).
 
Manufacturer Narrative
The user reported that several known u+ donor samples also resulted as u- with hea beadchip.For hea beadchip plates that had the aberrant false-negative fy(a) and u results, lower probe signal intensities were seen.For the fya/fyb probes, this resulted in the adjusted intensity ratio (delta value) falling within or around the lower gray zone region resulting in false-negative fy(a) results.The lower probe signal intensities also led to increased low signal (ls) calls on probes for the s and s antigens leading to an aberrant u- result.A product notification (correction under §806) was issued to consignees providing guidance for users to review the adjusted signal intensity ratio (delta value) on samples testing fy(a-) and to retest samples if the delta value is around or within the lower gray zone, and to repeat samples with the assigned phenotype s(ls), s(ls), u(0) to verify the results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISETYPE HEA MOLECULAR BEADCHIP TEST
Type of Device
MOLECULIAR ERYTHROCYTE TYPING TEST
Manufacturer (Section D)
BIOARRAY SOLUTIONS
35 technology drive, suite 100
warren NJ 07059
Manufacturer (Section G)
BIOARRAY SOLUTIONS
35 technology drive, suite 100
warren NJ 07059
Manufacturer Contact
howard yorek
35 technology drive, suite 100
warren, NJ 07059
6784184738
MDR Report Key12965165
MDR Text Key289885979
Report Number3005967741-2021-00002
Device Sequence Number1
Product Code PEP
UDI-Device Identifier10888234102618
UDI-Public10888234102618
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP130026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2023
Device Model Number800-20202-96
Device Catalogue Number800-20202-96
Device Lot Number21-145-V
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/08/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number5967741-02/09/2022-001-C
Patient Sequence Number1
-
-